Multiparametric MRI fusion-guided biopsy for the diagnosis of prostate cancer

To discuss the timing, benefits, limitations and current controversies of multiparametric magnet resonance imaging (mpMRI) combined with fusion-guided biopsy and consider how additional incorporation of multivariable risk stratification might further improve prostate cancer diagnosis.

Saved in:
Bibliographic Details
Main Authors: Kesch, Claudia (Author) , Schütz, Viktoria (Author) , Dieffenbacher, Svenja (Author) , Bonekamp, David (Author) , Hadaschik, Boris (Author) , Hohenfellner, Markus (Author) , Radtke, Jan Philipp (Author)
Format: Article (Journal)
Language:English
Published: March 2018
In: Current opinion in urology
Year: 2018, Volume: 28, Issue: 2, Pages: 172-177
ISSN:1473-6586
DOI:10.1097/MOU.0000000000000461
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1097/MOU.0000000000000461
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-urology/Fulltext/2018/03000/Multiparametric_MRI_fusion_guided_biopsy_for_the.13.aspx
Get full text
Author Notes:Claudia Kesch, Viktoria Schütz, Svenja Dieffenbacher, David Bonekamp, Boris Alexander Hadaschik, Markus Hohenfellner, and Jan P. Radtke
Description
Summary:To discuss the timing, benefits, limitations and current controversies of multiparametric magnet resonance imaging (mpMRI) combined with fusion-guided biopsy and consider how additional incorporation of multivariable risk stratification might further improve prostate cancer diagnosis.
Item Description:Gesehen am 16.04.2020
Physical Description:Online Resource
ISSN:1473-6586
DOI:10.1097/MOU.0000000000000461